FAQ: Doctorpresso's Therapods AI-Powered Group Therapy Earbuds at CES 2026

What are Therapods and what do they do?

Therapods are AI-powered earbuds for virtual group therapy that integrate advanced AI and multimodal biosensing to track voice patterns, brainwaves, and heart rate variability, delivering real-time emotional insights with more than 90% accuracy.

Who is developing Therapods and when will they be showcased?

Therapods are being developed by Doctorpresso, a leading AI mental health technology company, and will be unveiled at CES 2026 in Las Vegas.

How do Therapods address challenges in mental healthcare?

Therapods aim to bridge gaps in mental healthcare by offering a scalable solution that addresses traditional barriers including cost, stigma, and limited access, while restoring critical nonverbal cues often lost in remote therapy.

What makes Therapods different from traditional therapy options?

Therapods deliver real-time emotion sensing and group interaction analysis at a fraction of traditional therapy costs while maintaining clinical-grade security and privacy standards.

What industry recognition has this technology received?

The technology earned a finalist position for the 2025 GLOMO Awards at Mobile World Congress and Doctorpresso’s work has been recognized through peer-reviewed studies and global award nominations.

What is Doctorpresso’s long-term vision for Therapods?

Doctorpresso aims to establish a preventive mental health ecosystem where emotional wellbeing becomes a seamless part of everyday life, and is exploring partnerships with corporations, telemedicine providers, and educational institutions to broaden Therapods’ reach.

How does the technology maintain user privacy and security?

Therapods maintain clinical-grade security and privacy standards while delivering personalized emotional insights through advanced AI and biosensing technology.

What will attendees experience at CES 2026 regarding Therapods?

At CES 2026, attendees will experience firsthand demonstrations of Therapods’ emotion-sensing and virtual group therapy applications, highlighting its potential to reshape digital mental healthcare.

Who is the CEO of Doctorpresso and what is their perspective on Therapods?

Hwanbo Jung is the CEO of Doctorpresso, who stated that ‘Therapods represent a major leap in accessible mental health technology’ by merging advanced AI with human-centered design to break down traditional barriers.

What types of organizations is Doctorpresso partnering with for Therapods?

Doctorpresso is exploring partnerships with corporations, telemedicine providers, and educational institutions to broaden Therapods’ reach and establish a preventive mental health ecosystem.